Frontlight ResearchEarly access
Trial site
Synergy Biomed Research Institute (SBRI)
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- HIV1 trial
- Stroke1 trial
- Tuberculosis1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company1 trial
- Gilead Sciences1 trial
- Global Alliance for TB Drug Development1 trial
- Janssen Research & Development, LLC1 trial
Running trials
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026